Viropharma Inc (VPHM) Return on Investment ROI from the third quarter of 2013 to third quarter of 2012 and for the year 2013, average high and low, overall ranking from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Viropharma Inc  (VPHM)


Viropharma Inc's ROI from its third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Viropharma Inc's ROI in the third quarter of 2013?
Viropharma Inc recorded a cumulative net loss of $-63 million during 12 months ending in the third quarter of 2013, resulting in a negative return on investment (ROI) of -6.1%.

Within the Healthcare sector 111 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2013 from 0 to 1942.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Investment Change TTM -21.54 % -25.86 % -27.98 % -13.19 % -7.33 %
Y / Y Net Income Change TTM - - - -83.27 % 75.59 %
Investment (TTM) in Millions 1,044 1,023 988 1,088 1,116
Return On Investment (TTM) -6.1 % -6.83 % -7 % 0.74 % 3.28 %
VPHM's Overall Ranking # 1942 # 0 # 0 # 0 #
Seq. Investment Change TTM -1.7 % -3.81 % -11.74 % -5.98 % -7.11 %
Seq. Net Income Change TTM - - - -78.82 % -40.29 %
Net Income (TTM) in Millions -63 -72 -77 9 43

VPHM Company Profile >> Back to VPHM Roi Comparisons >> See Annual VPHM Return On Investment



Return On Investment VPHM's Ranking
Within: No.
Industry # 12
Sector # 112
Overall # 1942

Return On Investment Statistics
High Average Low
-0.35 %
-0.94 %
-1.4 %
 







Financial Statements
Viropharma Inc's III. Quarter Investments $ 1,044 Millions VPHM's Balance sheet
Viropharma Inc's III. Quarter Income $ 4 Millions Quarterly VPHM's Income Statement
VPHM's Income by Division See VPHM's Income by Division


VPHM Annual Return On Investment (Dec 31 2012)
2012		 (Dec 31 2009)
2011


Total Investments in Millions 1,088 1,383 0 0 0
Y / Y Investment Growth -21.34 % - - - -
Net Income in Millions 6 -11 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.52 % -0.8 % - - -


Annual Roi Comment
In the fiscal year 2012 ROI improved to 0.52 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VPHM's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VPHM's Competitors
Subscribers only: Roi for Viropharma Inc's Suppliers
Subscribers only: Return On Investment for VPHM's Customers

Other Ratios
VPHM's Roa VPHM's Inventory Turnover Ratio VPHM's Growth Rates VPHM's Dividend Statistics
VPHM's Profitability Ratios VPHM's Asset Turnover Ratio VPHM's Dividend Growth
VPHM's Roe VPHM's Valuation Ratios VPHM's Financial Strength Ratios VPHM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2013, within Healthcare Sector ROI

Date modified: 2026-09-08T15:07:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.